Publicaciones en colaboración con investigadores/as de Centro de Investigacion Biomedica en Red de Diabetes y Enfermedades Metabolicas Asociadas (19)

2024

  1. Correction to: Insulin-degrading enzyme ablation in mouse pancreatic alpha cells triggers cell proliferation, hyperplasia and glucagon secretion dysregulation (Diabetologia, (2022), 65, 8, (1375-1389), 10.1007/s00125-022-05729-y)

    Diabetologia

2023

  1. Insulin-degrading enzyme (IDE) as a modulator of microglial phenotypes in the context of Alzheimer’s disease and brain aging

    Journal of Neuroinflammation, Vol. 20, Núm. 1

  2. Pharmacological activation of insulin-degrading enzyme improves insulin secretion and glucose tolerance in diet-induced obese mice

    Diabetes, Obesity and Metabolism, Vol. 25, Núm. 11, pp. 3268-3278

2022

  1. Evolutionary Origin of Insulin-Degrading Enzyme and Its Subcellular Localization and Secretion Mechanism: A Study in Microglial Cells

    Cells, Vol. 11, Núm. 2

  2. Insulin-degrading enzyme ablation in mouse pancreatic alpha cells triggers cell proliferation, hyperplasia and glucagon secretion dysregulation

    Diabetologia, Vol. 65, Núm. 8, pp. 1375-1389

  3. Primary Cilia in Pancreatic β- and α-Cells: Time to Revisit the Role of Insulin-Degrading Enzyme

    Frontiers in Endocrinology, Vol. 13

2021

  1. Effects of fasting and feeding on transcriptional and posttranscriptional regulation of insulin‐degrading enzyme in mice

    Cells, Vol. 10, Núm. 9

  2. Modulation of insulin sensitivity by insulin-degrading enzyme

    Biomedicines, Vol. 9, Núm. 1, pp. 1-38

  3. miR-126 contributes to the epigenetic signature of diabetic vascular smooth muscle and enhances antirestenosis effects of Kv1.3 blockers

    Molecular Metabolism, Vol. 53

2020

  1. Hepatic insulin-degrading enzyme regulates glucose and insulin homeostasis in diet-induced obese mice

    Metabolism: Clinical and Experimental, Vol. 113

  2. Intestinal fructose and glucose metabolism in health and disease

    Nutrients, Vol. 12, Núm. 1

  3. Modulation of Glial Responses by Furanocembranolides: Leptolide Diminishes Microglial Inflammation in Vitro and Ameliorates Gliosis In Vivo in a Mouse Model of Obesity and Insulin Resistance

    Marine drugs, Vol. 18, Núm. 8

2019

  1. Cortistatin regulates glucose-induced electrical activity and insulin secretion in mouse pancreatic beta-cells

    Molecular and Cellular Endocrinology, Vol. 479, pp. 123-132

  2. Pancreatic β-cell-specific deletion of insulin-degrading enzyme leads to dysregulated insulin secretion and β-cell functional immaturity

    American journal of physiology. Endocrinology and metabolism, Vol. 317, Núm. 5, pp. E805-E819

2015

  1. Glucagon increases beating rate but not contractility in rat right atrium. comparison with isoproterenol

    PLoS ONE, Vol. 10, Núm. 7

  2. Pancreatic alpha-cells from female mice undergo morphofunctional changes during compensatory adaptations of the endocrine pancreas to diet-induced obesity

    Scientific Reports, Vol. 5

2014

  1. Nutrient regulation of glucagon secretion: Involvement in metabolism and diabetes

    Nutrition Research Reviews, Vol. 27, Núm. 1, pp. 48-62

2013

  1. Insulin hypersecretion in islets from diet-induced hyperinsulinemic obese female mice is associated with several functional adaptations in individual β-cells

    Endocrinology, Vol. 154, Núm. 10, pp. 3515-3524

  2. Involvement of the Clock Gene Rev-erb alpha in the Regulation of Glucagon Secretion in Pancreatic Alpha-Cells

    PLoS ONE, Vol. 8, Núm. 7